Feeds:
Posts
Comments

Archive for September, 2009

See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to receive the Connection (~every two weeks) right here.

TODAY’S NEWS

Pfizer and Wyeth to sell off some Animal Health assets to Boehringer-Ingelheim.

Speaking of B-I, here’s a presentation from them on how they successfully use Twitter. Boehringer is one of the more engaged and interactive companies in the space.

Eli Lilly‘s Alimta improves survival for lung cancer.

RECOMMENDED

District/Regional Manager development workshops. If you’re looking to developing your FLMs in a variety of skills, our best-in-class training providers can customize a program for your needs. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!

PLUS

Podcast today discussing latest social media in pharma developments, and upcoming Digital Pharma conference in October. Archived here.

JUST FOR FUN

Is it candy? Or medicine? This poster‘s both funny and a bit…scary.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to receive the Connection (~every two weeks) right here.

TODAY’S NEWS

It’s going to be a big week for Social Media in Pharma. Here’s the scoop.

Cancer drug Nexavar shows efficacy in breast cancer – Bayer and Onyx Pharmaceuticals‘  cancer pill Nexavar has demonstrated impressive results in treating breast tumours, brokerage Baird said on Monday, citing an abstract from a medical congress…Patients given Nexavar plus Xeloda had a 74 percent improvement in the time they lived without their disease progressing….more

AstraZeneca and Nektar Therapeutics in big licensing deal – Under the agreement, AstraZeneca will develop Nektar’s late-stage drug to treat opioid-induced constipation, NKTR-118, and NKTR-119, which is in its early-stage studies to treat pain without the side effects of constipationmore

Avastin for melanoma? That could be exciting. Melanoma has been notoriously resistant to everything thrown at it.

RECOMMENDED

Negotiating Skills. Presentation Skills. There’s an Impactiviti partner for those. Our best-in-class training providers can customize a program for your needs. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!

PLUS

Everything you always wanted to know about Instructional Design Models. It’s actually a lot more than I want to know! Hat tip: Ellen Wagner

JUST FOR FUN

100% accuracy for the weather? Announcing…The Weather Channel Classic! (spoof)

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

It’s only Monday morning and already the news hopper here at Impactiviti is brim-full with pharma social media stuff. That’s a good thing!

The Biggest Deal – Finally, after months of cajoling from all quarters (and John Mack gets a big handclap for his relentless calls to make this happen), the FDA has decided to call a public hearing on the use of social media/Web 2.0 approaches to pharma communications. This makes a lot of us very happy! Fabio Gratton put this post out on Friday as the news broke, and you’ll also want to read John Mack’s overview of the specific questions FDA will seek to address. One word of caution – there can be a very long time lapse between holding hearings, and taking action, when you’re dealing with FDA. But hey – it’s a step in the right direction, anyway, and long overdue!

Also, finally, the FDA is now on Twitter. It’s just one-way communications about drug info, but once again – a start.

And, while we’re at it, the use of social media tools among healthcare professionals is getting more attention.

Plus, this week’s conference on Pharma Marketing (with lots of emphasis on eMarketing/Social Media:

PharmaMed

I’ll be speaking at this conference on “Where’s the low-hanging fruit in pharma social media?, and live-blogging/Twittering. There will also be a tweetup at Princeton’s Triumph Brewery on Wednesday evening – here’s the invite.

How about a live streaming audio event on Tuesday. Sure – there’s an app for that. John Mack hosts a discussion with some of the organizers of the upcoming Digital Pharma conference (yes, I’m included – I’m planning to be at four ePharma conferences this fall) at 11:00 am EST. Sign up here!

From last Friday – my listing of your Top Four Pharma Social Media resources.

Oh, and why is J&J leading the pack in pharma social media? Read this interesting interview with Marc Monseau. In my mind, here’s the money quote:

One of the unique aspects about Marc’s Twitter profile is that he openly represents Johnson & Johnson without losing his personal identity. This might not sound particularly groundbreaking; yet most pharmaceutical corporate Twitter profiles are stripped of personal identity, whilst most pharmaceutical communicators use Twitter for personal, non-corporate communication only and are cautious about mentioning their pharmaceutical employer.

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news) Here’s today’s edition.

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »

See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line version; you can sign up to receive the Connection (~every two weeks) right here.

TODAY’S NEWS

FDA clears new Novartis combo drug for HBP – The FDA has approved Novartis’ Valturna (aliskiren and valsartan) tablets, a medicine to target two key points within the renin system, also known as the renin angiotensin aldosterone system (RAAS)more

…but says “No” to Sanofi‘s insomnia drug. However, Sanofi did complete the purchase of the Merck half of Merial.

Amgen‘s “mobile rep” strategy for product launch –  Amgen Inc. is hiring flexible, mobile sales representatives as it builds a primary care sales force, a strategy that may allow for a more efficient product launch ahead of the expected regulatory approval of osteoporosis treatment denosumab in mid-October. The launch is likely to be the most important yet for the Thousand Oaks, Calif., biotech, as the drug focuses on primary care physicians in the U.S., a much wider target than its traditional specialty focus. Amgen’s job is made more difficult because the company, unlike traditional pharmaceuticals, is creating the sales force from scratchmore

RECOMMENDED

Virtual Hospital Training. Have to train Hospital sales reps? Maybe an interactive virtual hospital will help. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for information and recommendations!

PLUS

Big picture – what about the future of Big Pharma (I’ve believed for years that a de-verticalization of pharma companies into more compact and focused entities would be very smart). Take a look at this analysis.

JUST FOR FUN

Yummmmmy! And, a Friday bonus: Transparency – not!

———-

Subscribe to the Impactiviti blog via e-mail

Connect with Steve Woodruff

Read Full Post »

Glad you asked.

Impactiviti is a networking agency. We exist to help our pharma/biotech clients find ideal vendor/partners for training and marketing projects – that’s what pays the bills. But we’re also encouraging the use of social networking approaches in business communications, and our entire business model is built on person-to-person and on-line networking.

We help you find what you need. Sometimes that’s a new vendor, sometimes it’s contact with a peer in another company, sometimes it’s a new job (or employee), sometimes it’s information. It’s our goal to continually bring value to you by making new connections.

The income side our Impactiviti’s business model is a referral fee structure – when our clients turn to us for recommended suppliers, and we introduce targeted best-in-class vendor partners, we get paid based on win-win new business. This costs the client nothing, and the other networking services we provide “behind the scenes” also are provided free of charge. This is how we figure it – if we consistently add value with our recommendations and you like what we provide, you’ll talk about us and recommend us to others. Everyone wins.

Vendor selection is both an art and a science. Some vendors may be skilled in one area, but really aren’t the optimal choice in another. Your goal is to have the best “fit” for your need(s), and our goal is to provide you with an optimal match – saving you the time and hassle of trying to sort through pitches and claims by dozens of providers. And the wrong fit can be disastrous – lost time, lost money, and a blow to your reputation.

We also do some traditional paid consulting engagements on sales training strategy, technology, and social media strategy.

Here’s some of what we do to keep you informed and networked:

The Impactiviti Connection – an (almost) daily quick news digest plus analysis, links, and commentary. Sign up right here.

LinkedIn Networking Groups – we administer one for pharma sales/training/marketing professionals, and one for vendors/suppliers/consultants. Overview and link to sign up here.

Live-blogging of conferences – we attend numerous targeted conferences and feed information out in real-time (and post-event) via Twitter and blogger. Here’s the current listing of events.

We also present workshops on social media, and project definition/RFP design/vendor selection/vendor management.

Feel free to contact us (stevew at impactiviti dot com, or phone at 973-947-7429) to discuss any of your needs!

———-

Subscribe to the Impactiviti blog via e-mail

Connect with Steve Woodruff

Read Full Post »

Job Searching

If you’re looking for new positions in Pharma Sales/Training/Marketing, here are some places to look:

new MedPharmReps – pulls listings from multiple recruiter sites

SPBT Career Center Job Listings (SPBT = Society of Pharmaceutical and Biotech Trainers)

Indeed Job Search site (pulls from multiple on-line sites) – this link is for “pharmaceutical sales trainer“, you can put in other word combinations

JuJu Job Search site (pulls from multiple on-line sites) – this link is for “pharmaceutical sales trainer“, you can put in other word combinations

You may also want to try out Medzilla, or Google searches similar to this.

What other suggestions/sites do you have?

———-

Subscribe to the Impactiviti blog via e-mail

Connect with Steve Woodruff

Read Full Post »

It’s going to be a busy fall for pharma eMarketing/Communications conferences. Here are the four five I’ve committed to – hope to see you at one or more of the events:

PharmaMed

Sept. 23-24 – MedAdNews PharmaMed Marketing and Media conference, Princeton, NJ. I’ll be speaking at this conference on “Where’s the low-hanging fruit in pharma social media?, and live-blogging/Twittering.

—–

DigitalPharma

Oct. 19-21 – eXL’s Digital Pharma conference, Bridgewater, NJ. This event will be quite progressive, with more of an informal “unconference” format to maximize interaction. I’ll be co-leading a pre-conference workshop on the 19th on social media, and live-blogging/Twittering. Here’s a discount code for 15% your registration: P615WOO

—–

ePatient

Oct. 26-27 – Kru Research’s e-Patient Connections conference, Philadelphia, PA. This is an inaugural conference on a very important topic – how empowered patients are using e-platforms for health. I’ll be part of a panel on social networking, and live-blogging/Twittering.

—–

eComm

Nov. 3-4 – eyeforpharma’s 4th Annual eCommunication and On-line Marketing Summit, Philadelphia, PA. I’ll be part of a panel on social networking, and live-blogging/Twittering. Here’s a discount code to save $400 off your registration: SPEAK

PRSAbanner2

Nov. 7-10 – Public Relations Society of America (PRSA) Annual conference, San Diego, CA. Speaking as part of panel.

———-

Subscribe to the Impactiviti blog via e-mail

Connect with Steve Woodruff

Read Full Post »

« Newer Posts - Older Posts »